Should the FDA approve Big Pharma marketing drug treatments to healthy people?
“This week, the U.S. Food and Drug Administration (FDA) will consider allowing an anti-HIV drug to be promoted to otherwise healthy, HIV-free people as a purely preventative measure for the first time. If approved, Gilead Sciences will be able to market Truvada to anyone who might be considered “at risk” for contracting the disease based on lifestyle and other factors (such as sexual orientation). Normally, HIV-infected patients take Truvada to slow viral replication. Under the new guidelines, doctors would begin openly touting this therapy as a glorified prophylactic to people who do not have HIV based on fear they might contract it someday (and all at the low price of just $14,000 a year).
According to Truvada’s own website, treatment side-effects may include lactic acidosis, a serious medical condition that can lead to death. Truvada patients can suffer impaired kidney function and “serious liver problems” such as enlargement and hepatotoxicity. In lab tests, Truvada has also been shown to cause osteopenia or changes in bones that make them more susceptible to fractures.”
Via Natural News